ConductScience.org, home

Paper28617852

Dicumarol inhibits PDK1 and targets multiple malignant behaviors of ovarian cancer cells.

Zhang W and 8 others. PLoS One, 2017. Cited by 54 papers, by iCite.

Cite this record

ConductScience Library. Dicumarol inhibits PDK1 and targets multiple malignant behaviors of ovarian cancer cells. Papers, record 28617852. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28617852

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Dicumarol inhibits PDK1 and targets multiple malignant behaviors of ovarian cancer cells.
PubMed
Journal
PLoS One
PubMed
Year
2017
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
54
iCite
Relative citation ratio, by iCite
2.17
iCite
Revised in PubMed
2021-12-04
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang WWenjia
2Su JJing
3Xu HHuadan
4Yu SShanshan
5Liu YYanan
6Zhang YYong
7Sun LLiankun
8Yue YYinghttps://orcid.org/0000-0001-7657-6020
9Zhou XXiaoli

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DicumarolMajor topic
Neoplasm ProteinsMajor topic
Ovarian NeoplasmsMajor topic
Protein Serine-Threonine KinasesMajor topic
Apoptosis
Cell Line, Tumor
Cell Survival
Female
Glucose
Glycolysis
Humans
Mitochondrial Membranes
Pyruvate Dehydrogenase Acetyl-Transferring Kinase
Reactive Oxygen Species

Source PubMed

Download CSV of topics

References53

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127637302The History of Antithrombotic Therapy: The Discovery of Heparin, the Vitamin K Antagonists, and the Utility of Aspirin.Hematol Oncol Clin North Am2016https://conductscience.org/library/papers/27637302PubMed
223534412Antithrombotic activity of a newly synthesized coumarin derivative 3-(5-hydroxy-2,2-dimethyl-chroman-6-yl)-N-{2-[3-(5-hydroxy-2,2-dimethyl-chroman-6-yl)-propionylamino]-ethyl}-propionamide.Chem Biol Drug Des2013https://conductscience.org/library/papers/23534412PubMed
326483203JX06 Selectively Inhibits Pyruvate Dehydrogenase Kinase PDK1 by a Covalent Cysteine Modification.Cancer Res2015https://conductscience.org/library/papers/26483203PubMed
419657231HIF-1 prevents the overproduction of mitochondrial ROS after cytokine stimulation through induction of PDK-1.Cell Cycle2009https://conductscience.org/library/papers/19657231PubMed
527874079Crosstalk among proteome, acetylome and succinylome in colon cancer HCT116 cell treated with sodium dichloroacetate.Sci Rep2016https://conductscience.org/library/papers/27874079PubMed
621798343Developmental effects of coumarin and the anticoagulant coumarin derivative warfarin on zebrafish (Danio rerio) embryos.Reprod Toxicol2012https://conductscience.org/library/papers/21798343PubMed
717222789A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth.Cancer Cell2007https://conductscience.org/library/papers/17222789PubMed
826959013Computational Study on New Natural Compound Inhibitors of Pyruvate Dehydrogenase Kinases.Int J Mol Sci2016https://conductscience.org/library/papers/26959013PubMed
921904029Inhibitor-bound structures of human pyruvate dehydrogenase kinase 4.Acta Crystallogr D Biol Crystallogr2011https://conductscience.org/library/papers/21904029PubMed
1016518417Dicoumarol potentiates cisplatin-induced apoptosis mediated by c-Jun N-terminal kinase in p53 wild-type urogenital cancer cell lines.Oncogene2006https://conductscience.org/library/papers/16518417PubMed
1222240028Protein profiles in human ovarian cancer cell lines correspond to their metabolic activity and to metabolic profiles of respective tumor xenografts.FEBS J2012https://conductscience.org/library/papers/22240028PubMed
132578093Enhancement of mitomycin C cytotoxicity to hypoxic tumor cells by dicoumarol in vivo and in vitro.Cancer Res1985https://conductscience.org/library/papers/2578093PubMed
1424463645Synthesis, structure-activity relationship of iodinated-4-aryloxymethyl-coumarins as potential anti-cancer and anti-mycobacterial agents.Eur J Med Chem2014https://conductscience.org/library/papers/24463645PubMed
1526681918Targeting Tumor Metabolism for Cancer Treatment: Is Pyruvate Dehydrogenase Kinases (PDKs) a Viable Anticancer Target?Int J Biol Sci2015https://conductscience.org/library/papers/26681918PubMed
1627653744Targeting PSG1 to enhance chemotherapeutic efficacy: new application for anti-coagulant the dicumarol.Clin Sci (Lond)2016https://conductscience.org/library/papers/27653744PubMed
1726188907Coumarins as anticancer agents: a review on synthetic strategies, mechanism of action and SAR studies.Eur J Med Chem2015https://conductscience.org/library/papers/26188907PubMed
1825404640VER-246608, a novel pan-isoform ATP competitive inhibitor of pyruvate dehydrogenase kinase, disrupts Warburg metabolism and induces context-dependent cytostasis in cancer cells.Oncotarget2014https://conductscience.org/library/papers/25404640PubMed
1926750139Historical Hallmarks of Anticoagulation and Antiplatelet Agents.Curr Pharm Des2016https://conductscience.org/library/papers/26750139PubMed
201600837Dichloroacetate.Diabetes Care1992https://conductscience.org/library/papers/1600837PubMed
2119341700Monitoring phosphorylation of the pyruvate dehydrogenase complex.Anal Biochem2009https://conductscience.org/library/papers/19341700PubMed

See all 53 referencesDownload CSV of references

Cited by39

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.

PMIDTitleJournalYearIn PapersSource
42683253Natural compounds targeting glycolysis and TME in ovarian cancer: from metabolic crosstalk to therapeutic potential.Front Pharmacol2026https://conductscience.org/library/papers/42683253PubMed
42630972The Mechanisms of Ramulus Cinnamomi and Rhizoma Paridis in Gynecological Cancers: A Narrative Review.Cancer Manag Res2026https://conductscience.org/library/papers/42630972PubMed
42545560Liraglutide affects mitochondrial function and histone acetylation through the NQO1/SIRT3 pathway in diabetic kidney disease.Mol Cell Biochem2026https://conductscience.org/library/papers/42545560PubMed
42317327Glycolytic reprogramming in ovarian cancer: mechanisms, immune crosstalk, and therapeutic implications.Front Immunol2026https://conductscience.org/library/papers/42317327PubMed
42007213The role of circadian disruption, sleep dysregulation, lifestyle factors, and metabolic reprogramming in the pathogenesis and progression of ovarian cancer.J Natl Cancer Cent2026https://conductscience.org/library/papers/42007213PubMed
41756460Mechanism of action of two potent LRRC8/VRAC channel inhibitors.Res Sq2026https://conductscience.org/library/papers/41756460PubMed
41465397Herbal Composition Inhibits Mitochondrial Oxidative Phosphorylation to Prevent HER2-Positive Breast Cancer and Identifies Potential Active Compounds.Int J Mol Sci2025https://conductscience.org/library/papers/41465397PubMed
40631551Target identification of natural products in cancer with chemical proteomics and artificial intelligence approaches.Cancer Biol Med2025https://conductscience.org/library/papers/40631551PubMed
40314877Lactic acid metabolism: gynecological cancer's Achilles' heel.Discov Oncol2025https://conductscience.org/library/papers/40314877PubMed
40225420In silico docking, ADMET profiling, and bio-accessibility experimentation on Breynia retusa phytocompounds and in vitro validation for anti-proliferative potencies against ovarian carcinoma.3 Biotech2025https://conductscience.org/library/papers/40225420PubMed
40103473Antimicrobial Plant Peptides: Structure, Classification, Mechanism and Therapeutic Potential.Curr Top Med Chem2025https://conductscience.org/library/papers/40103473PubMed
39835210Incredible use of plant-derived bioactives as anticancer agents.RSC Adv2025https://conductscience.org/library/papers/39835210PubMed
39364049A comprehensive review on the potential of coumarin and related derivatives as multi-target therapeutic agents in the management of gynecological cancers.Front Pharmacol2024https://conductscience.org/library/papers/39364049PubMed
39206407Notch Signaling Suppression by Golden Phytochemicals: Potential for Cancer Therapy.Adv Pharm Bull2024https://conductscience.org/library/papers/39206407PubMed
38279745Phytotherapeutics in Cancer: From Potential Drug Candidates to Clinical Translation.Curr Top Med Chem2024https://conductscience.org/library/papers/38279745PubMed
38090580Research progress on the mechanism of glycolysis in ovarian cancer.Front Immunol2023https://conductscience.org/library/papers/38090580PubMed
37475858Growth hormone remodels the 3D-structure of the mitochondria of inflammatory macrophages and promotes metabolic reprogramming.Front Immunol2023https://conductscience.org/library/papers/37475858PubMed
37259418Phenolic Acids-Mediated Regulation of Molecular Targets in Ovarian Cancer: Current Understanding and Future Perspectives.Pharmaceuticals (Basel)2023https://conductscience.org/library/papers/37259418PubMed
36575479Dicoumarol: from chemistry to antitumor benefits.Chin Med2022https://conductscience.org/library/papers/36575479PubMed
36406733Recent advances in understanding the metabolic plasticity of ovarian cancer: A systematic review.Heliyon2022https://conductscience.org/library/papers/36406733PubMed

See all 39 cited byDownload CSV of cited by

Genes13

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28617852

GET https://conductscience.org/api/papers/v1/28617852/references?page=2